لابراتوار داروسازی دکتر عبیدی

دعبید | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: 26,050 1.36

Close Price: 25,780

	2026/04/20 Fiscal Year 2025/12/2112 Month	2025/03/10 Fiscal Year 2024/12/2012 Month	2024/03/05 Fiscal Year 2023/12/2112 Month
Net Profit to Sales	32.92	22.7	31.9
Gross Profit to Sales	35.98	23.6	38.38
Operating Margin	40.83	38.98	47.55
Gross Profit to Sales	58.39	55.5	62.38
Net Profit to Gross Profit	56.38	40.89	51.13
Return on Assets (ROA)	22.79	14.61	18.67
Return on Capital (%)	84.76	47.57	84.65
Return on Equity (ROE)	44.45	30.95	44.31
Working Capital Return	75.99	56.81	96.97
Fixed Asset Return	92.04	42.27	53.71
Loan Benefit Assessment	1.95	2.12	2.37
Current Ratio	1.79	1.77	1.45
Quick Ratio	1.15	0.94	0.71
Liquidity Ratio	0.08	0.06	0.02
Net Working Capital	62,461,671	34,332,160	21,822,967
Current Assets Ratio	0.68	0.59	0.62
Inventory Turnover	266.04	346.83	405
Receivables Collection Period	165.68	115.64	129.54
Inventory to Working Capital	0.81	1.08	1.64
Working Capital Turnover	2.31	2.5	3.04
Fixed Asset Turnover	2.8	1.86	1.68
Total Asset Turnover	0.69	0.64	0.59
Debt Ratio	0.49	0.53	0.58
Debt to Equity	0.95	1.12	1.37
Long-Term Debt to Equity	0.21	0.41	0.36
Current Debt to Equity	0.74	0.71	1.02
Equity Ratio	51.27	47.19	42.12
Debt Coverage Ratio	2.32	1.8	2.32

At a Glance